Observational studyFuture oncology (London, England)2024

Determinants of immune checkpoint inhibitor use and factors linked to neurological adverse events in Korean lung cancer.

Sang Hee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.